Publicité
Publicité
RLAY
Relay Therapeutics, Inc. Common Stock
7.99
USDSponsorisé
0.00
-0.04%
09 janv., 15:59 UTC -5
Fermé
Pré-marché
8.00
0.00
+0.06%
RLAY Rapports sur les bénéfices
Ratio de surprise positive
RLAY a dépassé 13 des 22 dernières estimations.
59%
Prochain rapport
Date du prochain rapport
24 févr. 2026
Estimate for Q4 25 (Revenue/ EPS)
$5.06M
/-$0.41
Variation implicite de Q3 25 (Revenue/ EPS)
--
/-4.65%
Variation implicite de Q4 24 (Revenue/ EPS)
--
/-8.89%
Relay Therapeutics, Inc. Common Stock earnings per share and revenue
On 06 nov. 2025, RLAY reported earnings of -0.43 USD per share (EPS) for Q3 25, missing the estimate of -0.42 USD, resulting in a -1.46% surprise. Revenue reached --, compared to an expected 186.52 mille, with a -100.00% difference. The market reacted with a -7.35% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 13 analystes forecast an EPS of -0.41 USD, with revenue projected to reach 5.06 million USD, implying an baisse of -4.65% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Relay Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Relay Therapeutics, Inc. Common Stock reported EPS of -$0.43, missing estimates by -1.46%, and revenue of $0.00, -100% below expectations.
How did the market react to Relay Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -7.35%, changed from $6.53 before the earnings release to $6.05 the day after.
When is Relay Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 24 févr. 2026.
What are the forecasts for Relay Therapeutics, Inc. Common Stock's next earnings report?
Based on 13
analystes, Relay Therapeutics, Inc. Common Stock is expected to report EPS of -$0.41 and revenue of $5.06M for Q4 2025.
Which companies are reporting earnings today?
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité